Synergistic antiviral activity against human adenovirus through combination of itraconazole and brincidofovir.

Saved in:
Bibliographic Details
Title: Synergistic antiviral activity against human adenovirus through combination of itraconazole and brincidofovir.
Authors: Zamzamy M; Research Department Virus Immunology, Leibniz Institute of Virology, Hamburg, Germany., Post S; Research Department Virus Immunology, Leibniz Institute of Virology, Hamburg, Germany., Ip WH; Research Department Viral Transformation, Leibniz Institute of Virology, Hamburg, Germany., Hahlin E; Research Department of Clinical Microbiology, Umeå University, Umeå, Sweden.; Umeå Centre for Microbial Research (UCMR), Umeå University, Umeå, Sweden.; Molecular Infection Biology Sweden (MIMS), Umeå University, Umeå, Sweden.; Science for Life Laboratory (SciLifeLab), Umeå University, Umeå, Sweden., Kühn S; Technology Platform Microscopy and Image Analysis, Leibniz Institute of Virology, Hamburg, Germany., Pirosu A; Research Department Virus Immunology, Leibniz Institute of Virology, Hamburg, Germany., Conze C; Technology Platform Microscopy and Image Analysis, Leibniz Institute of Virology, Hamburg, Germany., Baumdick M; Research Department Virus Immunology, Leibniz Institute of Virology, Hamburg, Germany.; Division for Regenerative Medicine and Immunology, III. Department of Medicine, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany., Bunders MJ; Research Department Virus Immunology, Leibniz Institute of Virology, Hamburg, Germany.; Division for Regenerative Medicine and Immunology, III. Department of Medicine, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany., Zecher BF; Research Department Virus Immunology, Leibniz Institute of Virology, Hamburg, Germany.; I. Department of Medicine, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany., Hoelzemer A; I. Department of Medicine, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.; Institute for Infection Research and Vaccine Development (IIRVD), University Medical Centre Hamburg-Eppendorf, Hamburg, Germany., Linder S; Institute for Medical Microbiology, Virology and Hygiene, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany., Arnberg N; Research Department of Clinical Microbiology, Umeå University, Umeå, Sweden.; Umeå Centre for Microbial Research (UCMR), Umeå University, Umeå, Sweden.; Molecular Infection Biology Sweden (MIMS), Umeå University, Umeå, Sweden.; Science for Life Laboratory (SciLifeLab), Umeå University, Umeå, Sweden., Dobner T; Research Department Viral Transformation, Leibniz Institute of Virology, Hamburg, Germany., Altfeld M; Research Department Virus Immunology, Leibniz Institute of Virology, Hamburg, Germany., Schloer S; Research Department Virus Immunology, Leibniz Institute of Virology, Hamburg, Germany.; Institute of Immunology, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.
Source: British journal of pharmacology [Br J Pharmacol] 2026 Apr; Vol. 183 (7), pp. 1578-1601. Date of Electronic Publication: 2025 Nov 28.
Publication Type: Journal Article
Journal Info: Publisher: Wiley Country of Publication: England NLM ID: 7502536 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5381 (Electronic) Linking ISSN: 00071188 NLM ISO Abbreviation: Br J Pharmacol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1476-5381
DOI:10.1111/bph.70258